Browse Results

  • Division: : Cancer Center

There are 164 clinical trial(s) matching your criteria.


MST18801 Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC): A Phase 3 Randomized, DoubleBlind, PlaceboControlled, Multicenter Clinical Trial of MST188 (Purified Poloxamer 188) Injection in Children with Sickle Cell Disease Experiencing VasoOcclusive Crisis

Investigator: Ofelia Alvarez

Institutional Protocol #: 20130444

National Clinical Trials Identifier: NCT01737814

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase III

Enrolling Since: 1/22/2014

Thyroid cancer and MMPs

Investigator: Sharon Elliot

Institutional Protocol #: 20057541

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Thyroid and Other Endocrine Cancers

Phase: N/A

Enrolling Since: 6/24/2008